Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | MGLL | Q99685 | 2/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 5/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.35 |
| ▸ | MLNR | O43193 | 1/20 | 0.35 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29400267 | 1.00 | CA2 (0.41) | CA2CA1MGLLPDK2ENPP2 | |
| SCHEMBL17427064 | 0.97 | CA1 (0.39) | CA2CA1MGLLPDK2ENPP2 | |
| SCHEMBL13388829 | 0.94 | PDK2 (0.41) | CA2CA1MGLLPDK2 | |
| SCHEMBL14508331 | 0.94 | PDK2 (0.41) | CA2CA1MGLLPDK2 | |
| SCHEMBL29633595 | 0.91 | CA2 (0.39) | CA2CA1ENPP2LPLLIPG | |
| SCHEMBL941721 | 0.91 | CA2 (0.39) | CA2CA1ENPP2LPLLIPG | |
| SCHEMBL23258928 | 0.90 | CA1 (0.39) | CA2CA1MGLLPDK2ENPP2 | |
| SCHEMBL31576190 | 0.89 | CA1 (0.41) | CA2CA1MGLLPDK2ENPP2 | |
| SCHEMBL806940 | 0.89 | CA1 (0.41) | CA2CA1MGLLPDK2ENPP2 | |
| SCHEMBL16633217 | 0.89 | PDK2 (0.36) | PDK2MLNRNR1I2CHRM2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| US-20230380457-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-30 | — | — | US | claimed |
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| US-20230363426-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2023-11-16 | — | — | US | claimed |
| US-11793220-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2023-10-24 | — | — | US | claimed |
| US-20220264914-A1 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. | 2022-08-25 | — | — | US | claimed |
| US-20220225646-A1 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. | 2022-07-21 | — | — | US | claimed |
| US-20220225647-A1 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. | 2022-07-21 | — | — | US | claimed |
| CN-113831287-A | Naphthalimide compound with active end and preparation method and application thereof | 上海工程技术大学 | 2021-12-24 | — | — | CN | claimed |
| US-12637466-B2 | Benzocarbazole-based compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| US-12629382-B2 | Therapy | VESTLANDETS INNOVASJONSSELSKAP AS (NO) | 2026-05-19 | — | — | US | disclosed |
| US-12635409-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-05-19 | — | — | US | disclosed |
| EP-3762382-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20260078104-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2026-03-19 | — | — | US | disclosed |
| WO-2003080559-A1 | OLIGOFLUORENYLENE COMPOUNDS | CANON KABUSHIKI KAISHA (JP) | 2003-10-02 | — | — | WO | disclosed |
| EP-1348711-A1 | LUMINESCENT ELEMENT AND DISPLAY | CANON KABUSHIKI KAISHA (JP) | 2003-10-01 | — | — | EP | disclosed |
| US-20030068535-A1 | Metal coordination compound, luminescence device and display apparatus | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2003-04-10 | — | — | US | disclosed |
| US-20030068526-A1 | Such as tetrakis(1-(5-heptyloxyphenyl)isoquinoline-C2,N) (pu-dichloro) iridium (III); for red luminescence; graphic arts | CANON KABUSHIKI KAISHA (JP) | 2003-04-10 | — | — | US | disclosed |
| EP-1238981-A2 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2002-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030068535-A1 | Metal coordination compound, luminescence device and display apparatus | CCNL2, CYC1, CYCS | CA2 919/4885CA1 1388/4885MGLL 348/4885 |
| US-12635409-B2 | Organic electroluminescent materials and devices | NSUN2, CTNND1, NSD1 | CA2 3216/4885CA1 3878/4885MGLL 1567/4885 |
| US-12637466-B2 | Benzocarbazole-based compound and organic light-emitting device comprising same | CYP1A1, CYP2E1, CYP3A4 | CA2 3491/4885CA1 3415/4885MGLL 3410/4885 |
| US-12629382-B2 | Therapy | NR3C1, MGMT, GRM3 | CA2 2160/4885CA1 1297/4885MGLL 4390/4885 |
| US-20260078104-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | ELOC, ELOVL1, EMC1 | CA2 1787/4885CA1 1997/4885MGLL 1304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.